Back to Search Start Over

Contribution of objectively measured grating acuity by sweep visually evoked potentials to the diagnosis of unexplained visual loss.

Authors :
de Souza Soares, Tarciana
Berezovsky, Adriana
Sacai, Paula Yuri
Fernandes, Arthur Gustavo
Rocha, Daniel Martins
Verna, Carina
de Freitas Dotto, Patrícia
Watanabe, Sung Eun Song
Salomão, Solange Rios
Source :
Graefe's Archive of Clinical & Experimental Ophthalmology; May2022, Vol. 260 Issue 5, p1687-1699, 13p
Publication Year :
2022

Abstract

Purpose: To investigate the diagnostic contribution of grating visual acuity (GVA) measured by sweep pattern-reversal visually evoked potentials (SPRVEP) in unexplained visual loss (UVL). Methods: This case-control study included adult patients under suspicion of UVL referred to SPRVEP and transient pattern-reversal visually evoked potentials (TPRVEP) testing. Optotype visual acuity (OVA) was measured by ETDRS 4-meter chart and GVA by SPRVEP. UVL patients were assigned into three distinctive categories, according to the presence of ocular disease, motivation, and electrophysiological evaluation, as follows: exaggerators, malingerers, and psychogenic. Healthy controls and patients with organic visual loss were also tested. Receiver operating characteristic (ROC) curve was constructed to evaluate the diagnostic performance of GVA and TPRVEP parameters. Results: A total of 76 patients with UVL were analyzed: 60 (79.0%) exaggerators, 11 (14.4%) malingerers, and 5 (6.6%) psychogenic. Controls were 49 subjects evaluated for TPRVEP and 28 subjects for SPRVEP. There were 13 patients with organic visual loss enrolled. Mean difference between OVA and GVA was 1.19±0.67 (median=0.84; 95% CI: 1.04 to 1.34) in UVL and 0.14 ±0.09 (median= 0.14; 95% CI: 0.08 to 0.20) in organic visual loss. The area under the ROC curve (AUC) of GVA to distinguish UVL from healthy controls was 0.998 with a cutoff of 0.09 logMAR showing specificity of 100% and sensitivity of 96.0%. Conclusions: GVA measured by SPRVEP had good diagnostic validity to discriminate patients with unexplained visual loss from healthy controls and patients with organic visual loss, demonstrating its contribution to the diagnosis of this condition. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
0721832X
Volume :
260
Issue :
5
Database :
Complementary Index
Journal :
Graefe's Archive of Clinical & Experimental Ophthalmology
Publication Type :
Academic Journal
Accession number :
156318715
Full Text :
https://doi.org/10.1007/s00417-021-05385-9